AMPLIA THERAPEUTICS LIMITED has not announced any current capital raises, but we are collecting interest for future raises.
1. Create Account
Complete your onboarding digitally in less than 3 minutes.
2. View Terms
View the full term sheet for the capital raise.
3. Bid for Allocation
Submit and track your bid online.
Amplia Therapeutics Limited (ASX:ATX) is an Australian pharmaceutical company that is advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Amplia has two core patent families over its FAK assets. Their ideology is that FAK is an increasingly important target in the field of cancer immunology and that FAK inhibition has the potential to sensitize treatment-resistant cancers to the existing chemotherapeutics. With FAK in mind, Amplia has a particular development focus in pancreatic and ovarian cancer.
226/55 Flemington Rd, Parkville VIC 3052, Australia